Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Deciphera Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$14.3

2024-01-31

Market Capitalization

$1.1 B

2024-01-31

Revenue

$134 M

FY, 2022

CreditSafe Score

?
Score changed on Feb 22, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021FY, 2022
Revenue25.0M42.1M96.1M134.0M
Cost of goods sold225.0K2.9M8.8M
Gross profit41.9M93.2M125.3M
Gross profit margin, %99.5%97.0%93.5%
General and administrative expense5.1M5.7M11.4M21.2M68.1M114.1M136.3M120.2M
Operating expense total17.6M25.8M50.9M104.1M225.7M313.1M393.3M308.0M
EBIT(17.6M)(25.8M)(50.9M)(104.1M)(200.7M)(271.2M)(300.1M)(182.7M)
EBIT margin, %-802.9%-644.4%-312.1%-136.3%
Interest expense2.2M106.0K95.0K84.0K67.0K
Pre tax profit(300.0M)(178.2M)
Net Income(19.8M)(25.9M)(50.3M)(99.9M)(192.3M)(266.5M)(300.0M)(178.9M)
EPS(2.4)

Footer menu